163 related articles for article (PubMed ID: 37244355)
1. Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients.
Oh JH; Lee S; Thor M; Rosenstein BS; Tannenbaum A; Kerns S; Deasy JO
Radiother Oncol; 2023 Aug; 185():109723. PubMed ID: 37244355
[TBL] [Abstract][Full Text] [Related]
2. Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes.
Oh JH; Kerns S; Ostrer H; Powell SN; Rosenstein B; Deasy JO
Sci Rep; 2017 Feb; 7():43381. PubMed ID: 28233873
[TBL] [Abstract][Full Text] [Related]
3. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer.
Kerns SL; Amidon Morlang A; Lee SM; Peterson DR; Marples B; Zhang H; Bylund K; Rosenzweig D; Hall W; De Ruyck K; Rosenstein BS; Stock RG; Gómez-Caamaño A; Vega A; Sosa-Fajardo P; Taboada-Valladares B; Aguado-Barrera ME; Parker C; Veldeman L; Fonteyne V; Bultijnck R; Talbot CJ; Symonds RP; Johnson K; Rattay T; Webb A; Lambrecht M; de Ruysscher D; Vanneste B; Choudhury A; Elliott RM; Sperk E; Herskind C; Veldwijk MR; Rancati T; Avuzzi B; Valdagni R; Azria D; Farcy Jacquet MP; Chang-Claude J; Seibold P; West C; Janelsins M; Chen Y; Messing E; Morrow G;
Radiother Oncol; 2022 Mar; 168():75-82. PubMed ID: 35077710
[TBL] [Abstract][Full Text] [Related]
4. Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy.
Lee S; Kerns S; Ostrer H; Rosenstein B; Deasy JO; Oh JH
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):128-135. PubMed ID: 29502932
[TBL] [Abstract][Full Text] [Related]
5. Integrated models for the prediction of late genitourinary complaints after high-dose intensity modulated radiotherapy for prostate cancer: making informed decisions.
De Langhe S; De Meerleer G; De Ruyck K; Ost P; Fonteyne V; De Neve W; Thierens H
Radiother Oncol; 2014 Jul; 112(1):95-9. PubMed ID: 24951017
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.
Kerns SL; Dorling L; Fachal L; Bentzen S; Pharoah PD; Barnes DR; Gómez-Caamaño A; Carballo AM; Dearnaley DP; Peleteiro P; Gulliford SL; Hall E; Michailidou K; Carracedo Á; Sia M; Stock R; Stone NN; Sydes MR; Tyrer JP; Ahmed S; Parliament M; Ostrer H; Rosenstein BS; Vega A; Burnet NG; Dunning AM; Barnett GC; West CM;
EBioMedicine; 2016 Aug; 10():150-63. PubMed ID: 27515689
[TBL] [Abstract][Full Text] [Related]
7. Machine learning on genome-wide association studies to predict the risk of radiation-associated contralateral breast cancer in the WECARE Study.
Lee S; Liang X; Woods M; Reiner AS; Concannon P; Bernstein L; Lynch CF; Boice JD; Deasy JO; Bernstein JL; Oh JH
PLoS One; 2020; 15(2):e0226157. PubMed ID: 32106268
[TBL] [Abstract][Full Text] [Related]
8. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer.
Kerns SL; Stone NN; Stock RG; Rath L; Ostrer H; Rosenstein BS
J Urol; 2013 Jul; 190(1):102-8. PubMed ID: 23376709
[TBL] [Abstract][Full Text] [Related]
9. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
Kerns SL; Stock R; Stone N; Buckstein M; Shao Y; Campbell C; Rath L; De Ruysscher D; Lammering G; Hixson R; Cesaretti J; Terk M; Ostrer H; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e21-8. PubMed ID: 23021708
[TBL] [Abstract][Full Text] [Related]
10. Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.
Ahmed M; Dorling L; Kerns S; Fachal L; Elliott R; Partliament M; Rosenstein BS; Vega A; Gómez-Caamaño A; Barnett G; Dearnaley DP; Hall E; Sydes M; Burnet N; Pharoah PD; Eeles R; West CM
Br J Cancer; 2016 May; 114(10):1165-74. PubMed ID: 27070714
[TBL] [Abstract][Full Text] [Related]
11. Voxel-Based Analysis for Identification of Urethrovesical Subregions Predicting Urinary Toxicity After Prostate Cancer Radiation Therapy.
Mylona E; Acosta O; Lizee T; Lafond C; Crehange G; Magné N; Chiavassa S; Supiot S; Ospina Arango JD; Campillo-Gimenez B; Castelli J; de Crevoisier R
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):343-354. PubMed ID: 30716523
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.
Kerns SL; Ostrer H; Stock R; Li W; Moore J; Pearlman A; Campbell C; Shao Y; Stone N; Kusnetz L; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1292-300. PubMed ID: 20932654
[TBL] [Abstract][Full Text] [Related]
13. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.
Barnett GC; Thompson D; Fachal L; Kerns S; Talbot C; Elliott RM; Dorling L; Coles CE; Dearnaley DP; Rosenstein BS; Vega A; Symonds P; Yarnold J; Baynes C; Michailidou K; Dennis J; Tyrer JP; Wilkinson JS; Gómez-Caamaño A; Tanteles GA; Platte R; Mayes R; Conroy D; Maranian M; Luccarini C; Gulliford SL; Sydes MR; Hall E; Haviland J; Misra V; Titley J; Bentzen SM; Pharoah PD; Burnet NG; Dunning AM; West CM
Radiother Oncol; 2014 May; 111(2):178-85. PubMed ID: 24785509
[TBL] [Abstract][Full Text] [Related]
14. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Wang V; Geybels MS; Jordahl KM; Gerke T; Hamid A; Penney KL; Markt SC; Freedman M; Pomerantz M; Lee GM; Rana H; Börnigen D; Rebbeck TR; Huttenhower C; Eeles RA; Stanford JL; Consortium P; Berndt SI; Claessens F; Sørensen KD; Park JY; Vega A; Usmani N; Mucci L; Sweeney CJ
Prostate; 2021 Jul; 81(10):683-693. PubMed ID: 33956343
[TBL] [Abstract][Full Text] [Related]
15. Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation.
Kishan AU; Marco N; Schulz-Jaavall MB; Steinberg ML; Tran PT; Juarez JE; Dang A; Telesca D; Lilleby WA; Weidhaas JB
Radiother Oncol; 2022 Feb; 167():226-232. PubMed ID: 34990726
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.
Kerns SL; Stock RG; Stone NN; Blacksburg SR; Rath L; Vega A; Fachal L; Gómez-Caamaño A; De Ruysscher D; Lammering G; Parliament M; Blackshaw M; Sia M; Cesaretti J; Terk M; Hixson R; Rosenstein BS; Ostrer H
Radiother Oncol; 2013 Jun; 107(3):372-6. PubMed ID: 23719583
[TBL] [Abstract][Full Text] [Related]
17. Is hormone therapy a protective factor for late hematuria after high-dose radiotherapy in prostate cancer?
Zapatero A; García-Vicente F; Sevillano D; Martín de Vidales C; Ferrer C; Torres JJ; Minguez R; Rabadán M
Urology; 2008 Nov; 72(5):1130-4. PubMed ID: 18400265
[TBL] [Abstract][Full Text] [Related]
18. A genome-wide pleiotropy scan for prostate cancer risk.
Panagiotou OA; Travis RC; Campa D; Berndt SI; Lindstrom S; Kraft P; Schumacher FR; Siddiq A; Papatheodorou SI; Stanford JL; Albanes D; Virtamo J; Weinstein SJ; Diver WR; Gapstur SM; Stevens VL; Boeing H; Bueno-de-Mesquita HB; Barricarte Gurrea A; Kaaks R; Khaw KT; Krogh V; Overvad K; Riboli E; Trichopoulos D; Giovannucci E; Stampfer M; Haiman C; Henderson B; Le Marchand L; Gaziano JM; Hunter DJ; Koutros S; Yeager M; Hoover RN; ; Chanock SJ; Wacholder S; Key TJ; Tsilidis KK
Eur Urol; 2015 Apr; 67(4):649-57. PubMed ID: 25277271
[TBL] [Abstract][Full Text] [Related]
19. Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients.
Schack LMH; Petersen SE; Nielsen S; Lundby L; Høyer M; Bentzen L; Overgaard J; Andreassen CN; Alsner J
Acta Oncol; 2017 Nov; 56(11):1514-1521. PubMed ID: 28844157
[TBL] [Abstract][Full Text] [Related]
20. Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients.
Schaake W; van der Schaaf A; van Dijk LV; van den Bergh ACM; Langendijk JA
PLoS One; 2018; 13(7):e0197757. PubMed ID: 30016325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
